Laser Photonics Advances Pharmaceutical Manufacturing with Innovative Laser Technology Solutions

### Advancements in Laser Technology: A New Era for Pharmaceutical Manufacturing

Laser Photonics Corporation (NASDAQ: LASE), a leader in the development of industrial laser systems, has recently taken a significant leap in enhancing pharmaceutical manufacturing with the installation of a pioneering pill drilling system. This system, installed at a client facility through LPC’s newly acquired subsidiary, Control Micro Systems, Inc., incorporates a Class I automated CO2 laser equipped with a specialized tablet fixture, fume extraction, and machine vision inspection. This advanced setup is not only designed to improve production efficiency for pills, tablets, and capsules but also serves as an effective anti-counterfeiting measure. The integration of such high-precision technology showcases LPC's commitment to meeting the stringent demands of the medical and pharmaceutical industries.

LPC's CEO, Wayne Tupuola, highlights that this innovative solution aligns with the company’s strategic research and development initiative aimed at diversifying into sectors like pharmaceuticals, wafers, and semiconductors. This expansion is part of an effort to enhance LPC's technological offerings and maintain a competitive edge in the rapidly evolving industrial landscape. With the growing importance of secure and efficient drug manufacturing processes, the installation of this laser system underscores LPC's role in addressing industry challenges while pushing the boundaries of what is possible in production technologies.

Moreover, the ongoing focus on sustainability within the manufacturing sector is reflected in LPC's broader mission. The company aims to disrupt the $46 billion sand and abrasives blasting market by providing advanced laser technologies for surface cleaning, rust removal, and corrosion control. By leveraging its cutting-edge innovations, LPC is not only catering to the immediate needs of the pharmaceutical and semiconductor industries but also contributing to a more sustainable manufacturing ecosystem. As the demand for high-quality, efficient production methods continues to rise, Laser Photonics positions itself as a key player in transforming industrial operations across various sectors.

In addition to their advancements in the pharmaceutical industry, Laser Photonics is also responding to the soaring demand for chip fabrication. The semiconductor market is projected to reach $1 trillion annually by 2030, driven by the needs of electronics, electric vehicles, and artificial intelligence. LPC’s recent acquisition of Control Micro Systems enhances their capabilities in laser wafer dicing, marking, and scribing technologies, which are critical for improving manufacturing efficiency in chip production.

With the introduction of products like the BlackStar laser wafer dicing system and advanced chip marking technologies, LPC demonstrates its commitment to supporting the semiconductor industry. By implementing high-speed laser processing equipment, LPC aims to help chip manufacturers optimize their operations to meet the growing demand for advanced chips in a post-COVID-19 world. Through these innovations, Laser Photonics is setting a new standard in industrial material processing, reinforcing its position as a leader in laser technology solutions.